Direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) has made transplantation of kidneys from HCV-infected donors to uninfected recipients (D+/R−) feasible. In a study recently published in AJKD, Craig E. Gordon et al conducted a systematic review of HCV D+/R− kidney transplantation coupled with DAA treatment.
If the embedded player above doesn’t work, please click here to watch the video interview. Special thanks to Drs Concepcion and Forbes for agreeing to do the interview!
To view this Original Investigation (Open Access), please visit AJKD.org
Title: Kidney Transplantation From Hepatitis C Virus–Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update
Author: Craig E. Gordon, Gaelen P. Adam, Michel Jadoul, Paul Martin, and Ethan M. Balk